Products

Notal Vision Home Optical Coherence Tomography (OCT) System
Notal Vision
Ophthalmology AI
The Notal Vision Home Optical Coherence Tomography (OCT) System, also known as SCANLY Home OCT, is an AI-based, patient self-operated device for remote monitoring of neovascular age-related macular degeneration (NV-AMD).

See all 1 product →

About Notal Vision

Notal Vision is a pioneering diagnostic services company dedicated to extending eye disease management from the traditional clinic setting to the patient’s home, aiming to improve vision outcomes through precision medicine. They leverage artificial intelligence (AI)-driven data interpretation to analyze the high volumes of data generated by patients performing self-tests at home, enabling a personalized, “on-demand” treatment regimen tailored to each patient’s disease activity. Their approach addresses the unmet diagnostic needs in ophthalmology by connecting patients and physicians beyond the clinic, bringing standard-of-care diagnostics into the home.

The company’s flagship product, the ForeseeHome® AMD Monitoring Program, is an FDA-cleared and Medicare-covered diagnostic tool designed for intermediate dry Age-related Macular Degeneration (AMD) patients at risk of progressing to wet AMD. This program helps detect the conversion to wet AMD earlier than routine eye exams, leading to earlier treatment intervention and better visual outcomes, as demonstrated in the AREDS2 HOME Study. Notal Vision is also advancing its pipeline with the SCANLY Home OCT system, an AI-powered, self-operated device that received FDA De Novo authorization in 2024. This Home OCT is intended for visualizing intraretinal and subretinal hypo-reflective spaces in neovascular AMD (nAMD) eyes, providing segmentation and volume estimation of these biomarkers to support treatment monitoring between clinic visits. The Notal Vision Monitoring Center, directed by ophthalmologists, provides comprehensive support for these home monitoring services, including patient education, data analysis, and timely reporting to referring physicians.

Focus Areas

Age-related Macular Degeneration (AMD) Neovascular AMD (wet AMD) Remote Patient Monitoring Home Diagnostics Ophthalmology Artificial Intelligence Precision Medicine Retinal Diseases

Business Intelligence

Key InvestorsSoleus Capital, Ganot Capital, Elron, Evergreen, Arieli Group, Arch Grants
PartnershipsXiFin, Inc. (revenue cycle management), AllCloud (Kubernetes modernization), DRCR Retina Network (clinical trial collaboration)
AcquisitionsNone
TechnologyAI-driven data interpretation (Notal OCT Analyzer - NOA), cloud-based platform (Notal Health Cloud), patient-operated home diagnostic devices (ForeseeHome, SCANLY Home OCT), deep learning techniques, Kubernetes containerization
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Specialization
Notal Vision specializes in patient-centric ophthalmic remote monitoring services, extending retinal disease management from the clinic to the home. Their focus is on conditions such as Age-related Macular Degeneration (AMD), including both dry and wet forms, diabetic macular edema, and retinal vein occlusion.
Key Differentiators
Notal Vision stands out with its home-based, self-operated diagnostic devices like ForeseeHome (for dry AMD monitoring) and the recently FDA-authorized SCANLY Home OCT (for wet AMD monitoring). They leverage proprietary AI-enabled data analysis, specifically the Notal OCT Analyzer (NOA), for real-time, automated interpretation of patient data. The Notal Vision Monitoring Center provides comprehensive 24/7 support, patient engagement, and timely reporting to physicians, facilitating a precision medicine approach tailored to individual patient disease activity rather than fixed schedules. ForeseeHome is FDA-cleared and covered by Medicare and most private insurance, while SCANLY Home OCT has received FDA De Novo authorization and Breakthrough Device Designation.
Technology Stack
Their core technology includes AI-based data analytics, exemplified by the Notal OCT Analyzer (NOA) which performs automated detection and segmentation of retinal hypo-reflective spaces from OCT images. The infrastructure is built on a scalable cloud-based platform, utilizing AWS and Kubernetes for containerization. Their diagnostic devices, such as ForeseeHome (employing Preferential Hyperacuity Perimetry - PHP) and SCANLY Home OCT (spectral-domain OCT), are tele-connected, automatically transmitting data to the Notal Health Cloud for analysis.
Physician Value Proposition
Notal Vision empowers physicians to achieve earlier detection of wet AMD, which is crucial for preserving functional vision. The remote monitoring programs provide continuous, objective insights into disease activity between office visits, enabling personalized and timely treatment decisions. The Notal Vision Monitoring Center significantly reduces the administrative burden on practice staff by handling patient education, enrollment, device logistics, ongoing support, and adherence monitoring. The AI algorithms offer highly repeatable and objective analysis of diagnostic data, enhancing confidence in patient management.
Physician Tip

For physicians, Notal Vision's tools offer a pathway to proactive and personalized patient care for retinal diseases. By integrating home-based monitoring, you can gain continuous insights into disease progression, allowing for earlier intervention and potentially better visual outcomes. Leverage the Notal Vision Monitoring Center to offload administrative tasks related to remote monitoring, freeing up your staff to focus on in-clinic patient care. The objective AI-driven data analysis can provide an additional layer of confidence in your treatment decisions, moving towards a more 'on-demand' treatment regimen based on real-time disease activity.

Notal Vision's platform is cloud-based (AWS, Kubernetes) for scalable data processing and analysis. They partner with revenue cycle management solutions like XiFin to streamline billing and patient financial services. Their home-based diagnostic devices are tele-connected, ensuring seamless and automatic data transmission for physician review.

Products by Notal Vision

1 product in the directory

Notal Vision Home Optical Coherence Tomography (OCT) System
Notal Vision
Ophthalmology AI
The Notal Vision Home Optical Coherence Tomography (OCT) System, also known as SCANLY Home OCT, is an AI-based, patient self-operated device for remote monitoring of neovascular age-related macular degeneration (NV-AMD).

What the Web Says

Notal Vision is a digital health company focused on remote patient monitoring for retinal diseases, particularly Age-related Macular Degeneration (AMD). Their products, such as ForeseeHome and SCANLY Home OCT, enable patients to self-image at home, with data analyzed by AI and reviewed by physicians. The company is generally viewed positively for its innovative approach to patient care and supportive work culture, though some employee reviews mention past management issues and slow software performance.

Overall: Mixed

Strengths

  • Innovative technology for remote patient monitoring of AMD.
  • Products like ForeseeHome and SCANLY Home OCT are easy for patients to use.
  • AI-powered analysis of patient data for early detection and personalized treatment.
  • Positive company culture and supportive environment for employees.
  • Focus on patient care and improving outcomes for AMD patients.
  • Management is often described as caring and progressive.

Limitations

  • Some past issues with management, including unexpected layoffs.
  • Software can sometimes be slow or clunky.
  • Concerns about job security and advancement opportunities.
  • Some employees have had negative experiences and left due to internal issues.
  • Learning curve for some aspects of the software.
  • Compliance can be an issue with at-home monitoring devices.

Based on reviews from: Indeed.com, Ophthalmology Times, Notal Vision (Company Website), Review of Optometry, G2, Capterra

Last updated: 2026-07-19

Videos

News, demos, and interviews about Notal Vision.

Loading videos...

Videos load interactively. If none appear, search YouTube for Notal Vision →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Notal Vision offers the ForeseeHome AMD Monitoring Program, an FDA-cleared, AI-enabled device for intermediate dry AMD patients to detect conversion to wet AMD. They also provide the FDA De Novo authorized SCANLY Home OCT, which uses the AI-based Notal OCT Analyzer (NOA) to monitor disease activity and treatment response in wet AMD patients by segmenting and quantifying retinal fluid.
Notal Vision's products, such as SCANLY Home OCT, have received FDA De Novo authorization, marking the first-ever approval of an AI algorithm for OCT images. The Notal Vision Monitoring Center operates as a Medicare-recognized Independent Diagnostic Testing Facility (IDTF) and adheres to CMS performance standards, utilizing a HIPAA-compliant web portal for physicians to review patient data and receive notifications.
Notal Vision's model involves no direct fees or costs to the referring practice, as the Notal Vision Monitoring Center handles billing the patient or their insurance for the monitoring program. ForeseeHome is covered by Medicare and most private insurance, while SCANLY Home OCT has established Category III CPT codes, with Notal Vision actively working to secure broader coverage and payment.
Notal Vision offers comprehensive support through its Monitoring Center, which handles patient education, enrollment, device shipment, and ongoing technical and adherence support. For practices, they provide assistance with setup, referral processing, and access to a HIPAA-compliant Eye Care Professional (ECP) Portal for 24/7 access to test results and compliance data.
Pivotal studies have validated the clinical performance and patient usability of Notal Vision's devices, demonstrating that the AI algorithm (Notal OCT Analyzer) shows strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces. For example, in trials, 97% of patients successfully obtained OCT images at home, with high usability and adherence rates, contributing to earlier detection and improved visual outcomes.
Notal Vision has partnered with Hadley, a nonprofit, to provide patients with educational resources and support for living with vision loss, including workshops and podcasts. Additionally, they collaborate with XiFin for revenue cycle management, aiming to streamline billing processes and improve the overall patient financial experience.
Founded in 2000, Notal Vision is a privately held company that has secured significant funding, including a Series D round, indicating strong investor confidence. They are committed to transforming ophthalmic diagnostics through their pipeline of home monitoring solutions and AI advancements, aiming to extend disease management beyond the clinic and improve patient outcomes.

Investors

Who's funded Notal Vision.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.